← Eichor
Condition: Retinitis Pigmentosa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Retinitis Pigmentosa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783High Resolution Retinal Imaging
Phase N/A · 1 location(s) · University of Pennsylvania · NCT01866371Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital
NA · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07292987Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
EARLY_Phase 1 · 2 location(s) · Frontera Therapeutics · NCT05874310A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06092346Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Phase 2 · 14 location(s) · jCyte, Inc · NCT06912633Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NA · 1 location(s) · Science Corporation · NCT07266584Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer
Phase N/A · 1 location(s) · Sheba Medical Center · NCT02014389Experimental and Clinical Studies of Retinal Stimulation
NA · 1 location(s) · University of Michigan · NCT03635645A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Phase 1/Phase 2 · 5 location(s) · BlueRock Therapeutics · NCT06789445ARPKD Database Study
Phase N/A · 6 location(s) · Children's Hospital of Philadelphia · NCT01401998Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
Phase 1/Phase 2 · 1 location(s) · Frontera Therapeutics · NCT06492850Study of BEST1 Vitelliform Macular Dystrophy
Phase N/A · 3 location(s) · Columbia University · NCT05809635An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06936787Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations i
Phase 1 · 1 location(s) · VeonGen Therapeutics GmbH · NCT06291935Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NA · 3 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07126470Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Phase 1/Phase 2 · 1 location(s) · Mahidol University · NCT06242379Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Caus
Phase N/A · 36 location(s) · Jaeb Center for Health Research · NCT05589714Clinical Registry Investigating Bardet-Biedl Syndrome
Phase N/A · 1 location(s) · Marshfield Clinic Research Foundation · NCT02329210GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Phase N/A · 1 location(s) · Okuvision GmbH · NCT07548944Natural History Study of Patients With EYS-Associated RP
Phase N/A · 1 location(s) · Sensor Technology for Deafblind · NCT07228793Pilot Study of AuTNA I
NA · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT05853107Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Phase 1/Phase 2 · 3 location(s) · AAVantgarde Bio Srl · NCT06591793The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Phase 1 · 1 location(s) · University of Rochester · NCT06319872Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Phase 1/Phase 2 · 1 location(s) · Chigenovo Co., Ltd · NCT06952842Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Phase 1/Phase 2 · 2 location(s) · Ace Cells Lab Limited · NCT06787482
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.